Related Experiment Video
Updated: May 14, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Epigenetic changes in diabetes
1Epigenetics in Human Health and Disease Laboratory, Baker IDI Heart & Diabetes Institute, The Alfred Medical Research and Education Precinct, Melbourne, Victoria 3004, Australia.
Clinical Genetics
|February 13, 2013
Summary
Epigenetics plays a crucial role in diabetes development and complications, influencing gene expression in response to environmental factors. Understanding these epigenetic changes offers new therapeutic avenues for managing diabetes and its long-term effects.
Area of Science:
- Endocrinology
- Genetics
- Molecular Biology
Background:
- Diabetes mellitus is a complex, multifactorial disease influenced by genetics and environmental factors.
- Emerging evidence highlights the significant role of epigenetics in diabetes pathogenesis.
- Epigenetic modifications can alter gene expression in response to metabolic and environmental cues.
Purpose of the Study:
- To explore the contribution of epigenetic mechanisms to diabetes development and progression.
- To investigate how epigenetic changes influence susceptibility to diabetic complications.
- To understand the molecular basis of metabolic memory in diabetes.
Main Methods:
- Review of epidemiological and experimental animal studies.
- Analysis of epigenetic processes at the chromatin level.
- Investigation of gene expression changes in response to metabolic state and hyperglycemia.
Main Results:
- Epigenetic processes mediate the impact of environmental factors on diabetes-related gene expression.
- Epigenetic mechanisms contribute to both the predisposition to diabetes and the development of its complications.
- Early hyperglycemia exposure can induce persistent epigenetic changes, leading to a 'metabolic memory' of complications.
Conclusions:
- Epigenetic modifications are critical in diabetes pathogenesis and the development of long-term complications.
- Understanding these molecular events is key to developing novel therapeutic strategies.
- Targeting epigenetic pathways may offer new ways to prevent, reverse, or slow diabetic complications.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...